HLscience Co. Ltd (239610) — Capital Reinvestment Ratio
HLscience Co. Ltd (239610) has a Capital Reinvestment Ratio of 7.14x as of September 2022, meaning it reinvests 7% of its operating cash flow (₩420.13 Million) in capital expenditures (₩3.00 Billion). See 239610 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
HLscience Co. Ltd Capital Reinvestment Ratio (2014–2022)
This chart tracks HLscience Co. Ltd's Capital Reinvestment Ratio across 9 annual periods. Check 239610 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for HLscience Co. Ltd (2014–2022)
Year-by-year Capital Reinvestment Ratio for HLscience Co. Ltd from 2014 to 2022. For live market cap and broader valuation context, see HLscience Co. Ltd (239610) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.87x | ₩3.95 Billion | ₩11.34 Billion | ▲ +66.0% |
| 2021 | 1.73x | ₩10.56 Billion | ₩18.25 Billion | ▲ +1768.5% |
| 2020 | 0.09x | ₩14.97 Billion | ₩1.38 Billion | ▼ -73.7% |
| 2019 | 0.35x | ₩21.38 Billion | ₩7.51 Billion | ▲ +810.0% |
| 2018 | 0.04x | ₩13.02 Billion | ₩502.80 Million | ▼ -95.5% |
| 2017 | 0.85x | ₩5.83 Billion | ₩4.99 Billion | ▲ +10.8% |
| 2016 | 0.77x | ₩5.53 Billion | ₩4.27 Billion | ▲ +246.4% |
| 2015 | 0.22x | ₩3.10 Billion | ₩691.75 Million | ▲ +36.2% |
| 2014 | 0.16x | ₩2.31 Billion | ₩378.21 Million | — |